800PPhase II study of prednisone-dexamethasone switch in metastatic castration resistant prostate cancer (mCRPC) patients treated with abiraterone and prednisone (AA+P)R. Lozano Mejorada,N. Romero Laorden,A. Jayaram,Francisco Javier Perosanz López,M.I. Sáez, R. Villatoro, A. Montesa,Irene Moreno, M. Ruiz Vico, M. García Ferrón, J. Rogado,Y. Cendón Flórez,P. Nombela Blanco,Leonor Rivera,G. Grau,J.J. Cruz Hernandez,D. Lorente Estelles,Gerhardt Attard,E. Castro Marcos,D. Olmos HidalgoANNALS OF ONCOLOGY（2017）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
